Research comparison
CJC-1295 vs Sermorelin
Side-by-side comparison of research status, mechanisms, pharmacokinetics, and administration routes.
Research Status
Preclinical
Approved
Half-Life
6–8 days (due to DAC albumin binding)
10–20 minutes
Mol. Weight
3647.28 Da
3357.88 Da
Admin Routes
subcutaneous
subcutaneous, intravenous
Categories
Growth Hormone Axis
Growth Hormone Axis, Anti-Aging & Longevity
Interaction
No interaction data on file
Mechanism
Pharmacokinetics
Research Findings
Safety
Related comparisons